Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2019.100879
Abstract: We report a case of a 73-year-old man diagnosed with pulmonary pleomorphic carcinoma who showed profound durable response after a single treatment with pembrolizumab. The patient underwent a diagnostic workup in our hospital due to… read more here.
Keywords: pulmonary pleomorphic; durable response; treatment; pleomorphic carcinoma ... See more keywords
Successful control of intestinal bleeding from metastasis of pulmonary pleomorphic carcinoma with pembrolizumab: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031220
Abstract: Rationale: Pulmonary pleomorphic carcinoma is a rare tumor with a poor prognosis and has no standard chemotherapy. We herein report a case of small intestinal metastasis of pulmonary pleomorphic carcinoma that resulted in intestinal bleeding… read more here.
Keywords: pleomorphic carcinoma; metastasis pulmonary; report; pulmonary pleomorphic ... See more keywords
Ringed fluorodeoxyglucose uptake predicted poor prognosis after resection of pulmonary pleomorphic carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiothoracic Surgery"
DOI: 10.1186/s13019-022-01799-6
Abstract: Background Pulmonary pleomorphic carcinoma (PPC) is a relatively rare and poorly differentiated non-small cell carcinoma. This study aimed to investigate the clinicopathological features including programmed cell death ligand 1 (PD-L1) expression status in patients with… read more here.
Keywords: pulmonary pleomorphic; pleomorphic carcinoma; resection; prognosis ... See more keywords
Pulmonary Pleomorphic Carcinoma Mimicking Primary Sarcoma of the Neck: A Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Interventions in Aging"
DOI: 10.2147/cia.s296875
Abstract: Abstract We describe our challenge in diagnosing an unusual and rapidly progressing case of pulmonary pleomorphic carcinoma (PPC)—a rare, poorly differentiated, or undifferentiated non-small-cell carcinoma that can metastasize locally or distantly and has a poor… read more here.
Keywords: pulmonary pleomorphic; case; pleomorphic carcinoma; neck ... See more keywords
A Partial Response of Pulmonary Pleomorphic Carcinoma to Camrelizumab (PD1 Monoclonal Antibody) Monotherapy: A Case Report
Sign Up to like & getrecommendations! Published in 2020 at "OncoTargets and therapy"
DOI: 10.2147/ott.s279004
Abstract: Abstract We report a case of a 68-year-old man diagnosed with pulmonary pleomorphic carcinoma who showed partial response after a single treatment with camrelizumab (PD1 monoclonal antibody). The patient’s tumor was positive for programmed cell… read more here.
Keywords: pulmonary pleomorphic; camrelizumab; partial response; pleomorphic carcinoma ... See more keywords
Simultaneous Pseudoprogression and an Immune-related Adverse Event of Pulmonary Pleomorphic Carcinoma after Combined Therapy with Cytotoxic Anticancer Agents and Immune Checkpoint Inhibitor
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8916-21
Abstract: Pulmonary pleomorphic carcinoma is rare among lung tumors. Pulmonary pleomorphic carcinoma is resistant to chemotherapy. However, treatment with taxane anticancer agents and immune checkpoint inhibitors has been reported to be effective. When using immune checkpoint… read more here.
Keywords: pleomorphic carcinoma; immune checkpoint; agents immune; pulmonary pleomorphic ... See more keywords